Department of Radiotherapy and Radiation Oncology, Leopoldina Hospital, Schweinfurt 97421, Germany.
Cancer Biol Med. 2014 Sep;11(3):145-61. doi: 10.7497/j.issn.2095-3941.2014.03.001.
Head and neck cancers (HNCs) are aggressive tumors that typically demonstrate a high glycolytic rate, which results in resistance to cytotoxic therapy and poor prognosis. Due to their location these tumors specifically impair food intake and quality of life, so that prevention of weight loss through nutrition support becomes an important treatment goal. Dietary restriction of carbohydrates (CHOs) and their replacement with fat, mostly in form of a ketogenic diet (KD), have been suggested to accommodate for both the altered tumor cell metabolism and cancer-associated weight loss. In this review, I present three specific rationales for CHO restriction and nutritional ketosis as supportive treatment options for the HNC patient. These are (1) targeting the origin and specific aspects of tumor glycolysis; (2) protecting normal tissue from but sensitizing tumor tissue to radiation- and chemotherapy induced cell kill; (3) supporting body and muscle mass maintenance. While most of these benefits of CHO restriction apply to cancer in general, specific aspects of implementation are discussed in relation to HNC patients. While CHO restriction seems feasible in HNC patients the available evidence indicates that its role may extend beyond fighting malnutrition to fighting HNC itself.
头颈部癌症(HNCs)是侵袭性肿瘤,通常表现出高糖酵解率,导致对细胞毒性治疗的耐药性和预后不良。由于这些肿瘤的位置特殊,会严重影响进食和生活质量,因此通过营养支持来预防体重减轻成为重要的治疗目标。限制碳水化合物(CHO)的摄入并以脂肪代替,主要是酮饮食(KD),已被建议用于适应肿瘤细胞代谢的改变和与癌症相关的体重减轻。在这篇综述中,我提出了三种针对 CHO 限制和营养性酮症作为 HNC 患者支持性治疗选择的具体理由。这些是:(1)针对肿瘤糖酵解的起源和特定方面;(2)保护正常组织免受辐射和化学疗法引起的细胞杀伤,同时使肿瘤组织敏感化;(3)支持身体和肌肉质量的维持。虽然 CHO 限制的大多数益处适用于一般癌症,但与 HNC 患者相关的实施的具体方面进行了讨论。虽然 CHO 限制在 HNC 患者中似乎可行,但现有证据表明,其作用可能不仅限于对抗营养不良,还可能对抗 HNC 本身。